CDKN2A/P16-INK4A Rekombinanter Antikörper

CDKN2A/P16-INK4A Rekombinant Antikörper für WB, IHC, IF/ICC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, IHC, IF/ICC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

241438C7

Kat-Nr. : 81373-8-PBS

Synonyme

p16, p16 INK4, P16 INK4A, p16-INK4, p16INK4A



Geprüfte Anwendungen

Produktinformation

81373-8-PBS bindet in WB, IHC, IF/ICC, Indirect ELISA CDKN2A/P16-INK4A und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen CDKN2A/P16-INK4A fusion protein Ag1328
Vollständiger Name cyclin-dependent kinase inhibitor 2A
Berechnetes Molekulargewicht 16 kDa
Beobachtetes Molekulargewicht 16 kDa
GenBank-ZugangsnummerBC021998
Gene symbol CDKN2A
Gene ID (NCBI) 1029
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

CDKN2A generates several transcript variants which differ in their first exons. At least three alternatively-spliced variants encoding distinct proteins proteins were reported. Two of them named p16-INK4 and p14 are sharing 50% identity. P16 plays an essential role in regulating the cell cycle, and mutations in p16 increase the risk of developing various cancers, including melanoma. Long-term p16(INK4a) expression pushes cells to enter senescence, an irreversible cell-cycle arrest that precludes the growth of would-be cancer cells but also contributes to cellular aging (PMID: 24136988).